Key terms

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MRK news

Yesterday 5:06am ET Merck & Company: Balancing Growth Prospects Against Rising Operational Challenges Apr 08 2:43pm ET Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential Apr 08 10:07am ET Merck price target raised to $143 from $140 at Berenberg Apr 06 12:15am ET Merck & Company (MRK) Receives a Buy from Cantor Fitzgerald Apr 04 12:10pm ET Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call Apr 04 6:49am ET Merck initiates Phase 3 clinical trial of MK-1084 Apr 03 8:11am ET Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial Apr 02 4:25am ET Cantor Fitzgerald Remains a Buy on Merck & Company (MRK) Mar 29 3:06am ET Buy Rating on Merck & Co. Affirmed by Daina Graybosch Amidst WINREVAIR’s Market Potential and Efficacy Mar 28 9:00am ET Merck price target raised to $142 from $139 at Truist Mar 28 7:05am ET PDS Biotechnology price target lowered to $5 from $16 at Alliance Global Partners Mar 28 6:48am ET Merck: EC approves Keytruda plus chemotherapy to treat NSCLC Mar 28 12:20am ET Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK) Mar 27 9:56am ET Early notable gainers among liquid option names on March 27th Mar 27 7:19am ET Winrevair label represents ‘most bullish scenario’ for Merck, says BofA Mar 27 6:12am ET Merck price target raised to $135 from $130 at Wells Fargo Mar 26 7:56pm ET Merck & Co. Buy Rating Affirmed on Strong Sotatercept Outlook and Robust Growth Trajectory Mar 26 6:23pm ET Merck confirms FDA approval of WINREVAIR Mar 26 4:58pm ET Merck’s hypertension drug Sotatercept gains FDA approval, Bloomberg says Mar 25 4:14pm ET Summit Therapeutics initiated with a Buy at Stifel Mar 22 7:06am ET Merck & Company (MRK) Receives a Buy from Truist Financial Mar 21 6:46am ET Merck: Phase 3 KEYLYNK-006 trial did not meet dual primary endpoints Mar 19 9:08am ET Merck: V116 vaccine for pneumococcal diseases show adult immune response Mar 18 8:30am ET Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Legend Biotech (LEGN) Mar 15 2:37pm ET Buy/Sell: Wall Street’s top 10 stock calls this week Mar 15 10:45am ET Merck call volume above normal and directionally bullish Mar 15 6:46am ET Merck says Phase 3 KEYNOTE-A18 trial met primary endpoint Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today Mar 13 5:21am ET Merck to conduct trials for HPV vaccine, Gardasil Mar 13 2:11am ET Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Merck & Company (MRK) Mar 12 12:25pm ET Moderna, Merck start two randomized trial in cancers, says RBC Capital

MRK Financials

1-year income & revenue

Key terms

MRK Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MRK Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms